From sleep apnea and liver disease to cravings, dementia and asthma flare-ups, a look at what published studies report, with notes on where evidence is still early.
Recap by typeshit. Full story at Making Sense of Diabetes.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
The rundown covers CagriSema, retatrutide, MariTide, VK2735 and Roche's enicepatide, which the company says cut weight by 15.5% on average in a mid-stage trial.
Zhavoronkov links recorded ARDD 2026 sessions, among them Lilly's Kevin Duffin speaking on tirzepatide and aging clocks.
Bikman says midface volume drops about 7% for every 10 kg lost, and that bariatric surgery patients see the same change.
Bikman cites research that midface volume falls about 7% for every 10 kg lost, and says the same happens after bariatric surgery or any big weight loss.
Loading…